BWXT to supply Ac-225 generation to Fusion Pharmaceuticals
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.

A message from Hydro, Inc.
A Technical Blueprint for EPU Equipment Upgrades: Increasing Reliability and Reducing Total Cost of Ownership
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
DOE, PNNL, and Commerce Dept. collaborate on Ra-226 recovery
A collaboration between the Department of Energy’s Office of Isotope R&D and Production and the Department of Commerce’s National Institute of Standards and Technology has recovered...
Reimagining nuclear materials for the future of medicine
Nuclear medicine has come a long way since Henri Becquerel first observed the penetrating energy of radioactive materials in 1896. Today, technetium-99m alone is used in more than 40 million...
Canada funds fusion-based copper-67 production project
The Canadian Medical Isotope Ecosystem, which is backed by the Canadian federal government’s Strategic Innovation Fund, has announced funding for a collaboration between Promation, Astral...

TerraPower announces second Ac-225 production facility
TerraPower Isotopes, a TerraPower subsidiary, plans to increase its actinium-225 production 20-fold by opening a new manufacturing facility in Philadelphia, Pa., and by expanding the capacity...

ANSTO-designed target increases Mo-99 yield
The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...
Westinghouse teams with Nordion and PSEG to produce Co-60 at Salem
Westinghouse Electric Company, Nordion, and PSEG Nuclear announced on Tuesday the signing of long-term agreements to establish the first commercial-scale production of cobalt-60 in a U.S....

NRC receives construction application for isotope production reactor
The Nuclear Regulatory Commission announced that it has received the first portion of a construction permit application from Oklo subsidiary Atomic Alchemy that requests permission to build...

Co-60 tariffs would undermine U.S. health care, SSWG warns
In a letter to the Office of the U.S. Trade Representative, the Source Security Working Group (SSWG) is urging the U.S. government to withhold from imposing tariffs on Canadian-orgin cobalt-60...

Clarity and Nusano agree on medical isotopes deal
Australia-based Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, has signed a supply agreement for copper-67 with Nusano, Inc., headquartered in California. Nusano...
Experts talk on developing the isotope supply chain
The American Nuclear Society recently hosted a webinar, “Securing the Isotope Supply Chain: A Growing Global Challenge,” featuring experts from a variety of private and public institutions...
